Priority-driven Collaborative Cancer Research Scheme - Cancer Australia

Cancer Australia

 Successful applicants for 2016 Round

(selected items pertinent to ovarian cancer)

  Sjoquist, Katrin
NHMRC Clinical Trials Centre
Phase II clinical trial of the PARP inhibitor, olaparib, in HR- deficient advanced breast and ovarian cancer in women without inherited BRCA1 or BRCA2 mutations
Co-funded by Cancer Australia and the National Breast Cancer Foundation

 Taylor, Natalie
Macquarie University
Hide and seek with hereditary cancer: Improving detection of colorectal cancer patients with a high risk of Lynch syndrome
Funded by Cancer Australia

 Thomas, David
Garvan Institute of Medical Research
A surveillance protocol for people at high risk of cancer using whole body magnetic resonance
Funded by the Australasian Sarcoma Study Group